FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
However, some individuals experience better tolerance when taken with food
M2pep-ADSC-Exos specifically target M2 microglia, substantially reducing their susceptibility to ferroptosis and enhancing neurological function in ischemic stroke mice
For cell lysates sample detection, caspase-3 activity in DCA treated cells were determined following the instructions of Caspase-3 Colorimetric Assay Kit (K106, Biovision, San Francisco, USA) with substrate Ac-DEVD-pNA and detected by a Synergy H1 Microplate Reader (Bio Tek, Winooski, USA)